Transplantation Direct (May 2022)

HLA Homozygosity and Likelihood of Sensitization in Kidney Transplant Candidates

  • Joshua A. Rushakoff, MD, MPP,
  • Loren Gragert, PhD,
  • Marcelo J. Pando, PhD,
  • Darren Stewart, MS,
  • Edmund Huang, MD,
  • Irene Kim, MD,
  • Stanley Jordan, MD,
  • Kelsi Lindblad, PhD,
  • Xiaohai Zhang, PhD,
  • Peter Lalli, PhD,
  • Jignesh K. Patel, MD, PhD,
  • Jon A. Kobashigawa, MD,
  • Evan P. Kransdorf, MD, PhD

DOI
https://doi.org/10.1097/TXD.0000000000001312
Journal volume & issue
Vol. 8, no. 5
p. e1312

Abstract

Read online

Background. Homozygosity for HLAs has been associated with adverse outcomes after viral infection as well as pregnancy-induced HLA sensitization. We sought to assess the relationship between HLA locus homozygosity and the level of HLA antibody sensitization. Methods. We measured sensitization using the calculated panel reactive antibody value for a large cohort of 147 461 patients added to the US OPTN/United Network for Organ Sharing kidney transplant waitlist between December 2014 and December 2019. We used multinomial logistic modeling to compare 62 510 sensitized patients to 84 955 unsensitized controls. Results. We found that the number of homozygous HLA loci was strongly associated with the level of sensitization. Within mildly, highly, or extremely sensitized candidates, women displayed a higher relative abundance of HLA homozygosity at multiple HLA loci as compared with men, with attenuation of this effect in Black candidates. In a multivariable logistic model, the number of homozygous HLA loci interacted with female sex but not with other factors associated with sensitization, including recipient ethnicity and a history of prior kidney transplant. Conclusions. This study shows that HLA homozygosity is an innate genetic factor that affects the likelihood of HLA sensitization. Further research is needed to identify the immunologic mechanisms that underlie this observation.